Skip to content

Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride

C52H64Cl2CuN16O4 — CID 139185524

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACcopper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride
SMILESCc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.[Cl-].[Cl-].[Cu+2]
InChIInChI=1S/4C13H16N4O.2ClH.Cu/c4*1-10-2-4-11(5-3-10)17-13(18)15-7-6-12-8-14-9-16-12;;;/h4*2-5,8-9H,6-7H2,1H3,(H,14,16)(H2,15,17,18);2*1H;/q;;;;;;+2/p-2
InChIKeyXGHNOZPDWVSSFM-UHFFFAOYSA-L
MW1111.64 g/mol
LogP2.33
Rot. Bonds16

About Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride

Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride (PubChem CID 139185524) has the molecular formula C52H64Cl2CuN16O4 and a molecular weight of 1111.64 g/mol. Its IUPAC name is copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride.

Molecular Properties

Compound NameCopper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride
PubChem CID139185524
Molecular FormulaC52H64Cl2CuN16O4
Molecular Weight1111.64 g/mol
Exact Mass1109.40
IUPAC Namecopper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride
SMILESCc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.[Cl-].[Cl-].[Cu+2]
InChIInChI=1S/4C13H16N4O.2ClH.Cu/c4*1-10-2-4-11(5-3-10)17-13(18)15-7-6-12-8-14-9-16-12;;;/h4*2-5,8-9H,6-7H2,1H3,(H,14,16)(H2,15,17,18);2*1H;/q;;;;;;+2/p-2
InChIKeyXGHNOZPDWVSSFM-UHFFFAOYSA-L
XLogP2.33
TPSA279.24 Ų
H-Bond Donors12
H-Bond Acceptors8
Rotatable Bonds16
Heavy Atoms75
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001111.64
LogP ≤ 52.33
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 108

Analyze Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride?
The IUPAC name of Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride (CID 139185524) is copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride.
What is the SMILES notation for Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride?
The canonical SMILES for Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride is Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.[Cl-].[Cl-].[Cu+2].
What is the InChIKey of Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride?
The InChIKey is XGHNOZPDWVSSFM-UHFFFAOYSA-L. The full InChI is InChI=1S/4C13H16N4O.2ClH.Cu/c4*1-10-2-4-11(5-3-10)17-13(18)15-7-6-12-8-14-9-16-12;;;/h4*2-5,8-9H,6-7H2,1H3,(H,14,16)(H2,15,17,18);2*1H;/q;;;;;;+2/p-2.
What are the key properties of Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride?
Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride has a molecular weight of 1111.64 g/mol, XLogP of 2.33, 16 rotatable bonds, 12 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride is sourced from PubChem (CID 139185524), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.